Solid tumors at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

14 organizations at AMP 2026 present work in solid tumors: 13 academic medical centres, children's hospitals and universities and 1 public organization. Between them they bring 75 presentations to the program. Most represented: Mayo Clinic (11 on the program), MD Anderson Cancer Center (9 on the program), Palmetto GBA (8 on the program). 14 of them have their own page in this guide. As of Sep 25, 2026.

All 298 organizations at AMP 2026 →

Showing 1–5 of 14 organizations

Organization	AMP 2026 Attendance
Mayo Clinic Rochester, MN
mayoclinic.org Med centres Academic medical center and health system whose laboratories develop and run clinical molecular and genomic testing.	Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Workshop hosted by Illumina Skagit 5, Lower Level, Arch at 800 Pike Talk Thu, Nov 12 10:45am–11:15am Part of Clinical Applications of Transcriptomics in Lymphomas and Leukemias New Insights from Gene Expression Profiling of Anaplastic Large Cell Lymphoma 608-609, Level 6, Arch at 705 Pike Hematopathology Plenary Thu, Nov 12 1:15pm–2:15pm Part of Solid Tumors Plenary Session DNA Methylation and Artificial Intelligence for the Diagnosis and Classification of CNS Tumors Ballroom ABC, Level 6, Arch at 705 Pike Solid Tumors Talk Fri, Nov 13 10:15am–10:35am Part of Technologist Innovation Session TT009 Assessment of X-Chromosome Inactivation Using Oxford Nanopore Technologies (ONT) Long-Read Sequencing 602-604, Level 6, Arch at 705 Pike Technologist Innovation Session Talk Fri, Nov 13 10:35am–10:55am Part of Technologist Innovation Session ID024 Evaluation of a Targeted Metagenomics Kit for Microbial Identification Using the V1-V2 Region of the 16S Ribosomal RNA Gene 602-604, Level 6, Arch at 705 Pike Technologist Innovation Session Session Fri, Nov 13 1:15pm–2:45pm Clinical Application of Long-read Sequencing Ballroom E, Level 6, Arch at 705 Pike Genetics 1:15pm–1:45pmFully Integrated SNV, Fusion, and Isoform Analysis of Cancer Drivers with Long-read RNA-seq for Improved Functional InterpretationUniversity of California, Santa Cruz 1:45pm–2:15pmImproving Long-Read Sequencing for Transcriptome and Amplicon Sequencing ApplicationsUniversity of California, Santa Cruz 2:15pm–2:45pmClinical Implementation of Long-Read Sequencing: From Targeted Assays to Genome SequencingStanford University School of Medicine Poster Fri, Nov 13 7:45am–8:00am Part of Platform Presentations of Selected HemePath Abstracts I H041 Validation and Clinical Application of Comprehensive DNA and RNA NGS for Measurable Residual Disease Assessment of Myeloid Neoplasms Talk Sat, Nov 14 10:15am–10:45am Part of Current and Emerging Methods for Structural Variants and Gene Fusions FISH vs. RNA sequencing for Structural Variant Detection in Solid Tumors: Strengths and Limitations Case-based comparison of break-apart FISH and RNA sequencing for finding gene rearrangements in solid tumors, including FFPE pitfalls. 611-614, Level 6, Arch at 705 Pike Hematopathology · Lab Management · Solid Tumors Session Sat, Nov 14 10:15am–11:45am Foundation Models in Molecular 608-609, Level 6, Arch at 705 Pike Informatics 10:15am–11:00amFrom AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?The University of Texas MD Anderson Cancer Center 11:00am–11:45amA Bioinformatician's Guide to Choosing Biological Foundation Models in 2026 Poster Sat, Nov 14 2:00pm–2:15pm Part of Platform Presentations of Selected Genetics Abstracts II G075 UGT1A1 Genotyping for Pharmacogenomics Testing: Is Sequencing Necessary? 608-609, Level 6, Arch at 705 Pike Talk Sat, Nov 14 2:30pm–3:00pm Part of Interactive Visualization Tools for Molecular Testing CNVpytor: Comprehensive Detection, Annotation, and Visualization of Germline and Somatic Copy Number Variations CNVpytor, a tool combining read depth and B-allele frequency to call and visualize germline and somatic copy number changes. 606-607, Level 6, Arch at 705 Pike Informatics Poster Sat, Nov 14 7:30am–7:45am Part of Platform Presentations of Selected Solid Tumors Abstracts I ST094 MET Exon 14 Skipping Discordance as a Tool for Quality Improvement in Clinical NGS Testing
MD Anderson Cancer Center Houston, TX
mdanderson.org Med centres Comprehensive cancer center and academic medical institution in Houston, with clinical molecular diagnostics laboratories.	Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop hosted by Thermo Fisher Scientific Skagit 2, Lower Level, Arch at 800 Pike Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Workshop hosted by Countable Labs Tahoma 2, Level 3, Arch at 800 Pike Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Workshop hosted by Illumina Skagit 1, Lower Level, Arch at 800 Pike Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias 608-609, Level 6, Arch at 705 Pike Hematopathology 10:15am–10:45amLong-Read Transcriptome Sequencing Enables Accessible Molecular Diagnostics for Pediatric LeukemiaUniversity of North Carolina at Chapel Hill 10:45am–11:15amNew Insights from Gene Expression Profiling of Anaplastic Large Cell LymphomaMayo Clinic Workshop Thu, Nov 12 12:00pm–12:30pm AMP Practice Guidelines Meet the Authors Series: Lung Guideline Update New lung cancer molecular testing recommendations from the updated joint practice guideline, with the evidence and process behind them. Innovation Spotlight Stage #2 Session Fri, Nov 13 10:15am–11:45am Accelerating the Impact of Molecular Profiling in Pediatric and Adolescent Young Adult (AYA) Tumors Ballroom E, Level 6, Arch at 705 Pike Hematopathology · Solid Tumors 10:15am–11:00amFrom Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA CancersBoston Children's Hospital/ Dana Farber Cancer Institute 11:00am–11:45amPresentation Title TBD Session Fri, Nov 13 1:15pm–2:45pm Menin Inhibitors and Targeted Therapy Resistance in AML 608-609, Level 6, Arch at 705 Pike Hematopathology 1:15pm–2:00pmMenin Inhibitor Use in Acute Myeloid LeukemiaJohns Hopkins 2:00pm–2:45pmDevelopment and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid LeukemiaUniversity of Michigan Workshop Fri, Nov 13 9:30am–10:00am Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies Electronic genome mapping weighed against karyotyping, FISH and optical mapping for structural variants, including marrow versus blood samples. Workshop hosted by Nabsys Innovation Spotlight Stage #1 Talk Sat, Nov 14 10:15am–11:00am Part of Foundation Models in Molecular From AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing? How well DNA foundation models actually perform on clinical genomic tasks, and how to judge which ones to trust. 608-609, Level 6, Arch at 705 Pike Informatics Talk Sat, Nov 14 10:15am–11:00am Part of Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors Minimal Residual Disease in Colorectal Cancer: Opportunities for therapeutic development Ballroom E, Level 6, Arch at 705 Pike Solid Tumors Poster Sat, Nov 14 1:45pm–2:00pm Part of Platform Presentations of Selected HemePath Abstracts II H078 Clinical Significance of Clonal Hematopoiesis Detected by Paired Plasma and Peripheral Blood Liquid Biopsy Testing in Patients with Solid Tumors 606-607, Level 6, Arch at 705 Pike Session Sat, Nov 14 2:30pm–4:00pm Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms 611-614, Level 6, Arch at 705 Pike Hematopathology · Technical Topics 2:30pm–2:45pmMeasurable Residual Disease Testing in Acute Myeloid Leukemia: Moving From Theory to PracticeVirginia Tech 2:45pm–4:00pmToward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid BiopsiesStanford University Talk Sat, Nov 14 3:00pm–3:30pm Part of Technical Advancement in Methylation Profiling Direct DNA Methylation Analysis by Single Molecule Real-Time Sequencing A transformer model reads polymerase kinetics from SMRT sequencing to call 5mC, 5hmC and 6mA base modifications directly. 608-609, Level 6, Arch at 705 Pike Technical Topics
Palmetto GBA Columbia, SC
palmettogba.com Gov/NGO Medicare Administrative Contractor that runs the MolDX program, setting coverage and reimbursement policy for molecular diagnostic tests.	Session Thu, Nov 12 10:15am–11:45am Technical Advancement in Spatial Genomics and Multi-omics 602-604, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amSpatial Multi-Omics Profiling in TissuesUniversity of Pennsylvania 11:00am–11:45amMolecular-Resolution Spatial Inference of Subcellular Transcriptional ProgramsUniversity of Michigan Session Fri, Nov 13 10:15am–11:45am Technologist Innovation Session 602-604, Level 6, Arch at 705 Pike Technical Topics 10:15am–10:35amTT009 Assessment of X-Chromosome Inactivation Using Oxford Nanopore Technologies (ONT) Long-Read SequencingMayo Clinic 10:35am–10:55amID024 Evaluation of a Targeted Metagenomics Kit for Microbial Identification Using the V1-V2 Region of the 16S Ribosomal RNA GeneMayo Clinic 10:55am–11:15amG010 Comparison of Manual Illumina PCR-Free and Hamilton NGS STAR Automated Library Preparation for Germline Whole Genome SequencingToronto General Hospital 11:15am–11:35amH010 Laboratory Developed Test Validation of FL24Cx: A Gene Expression Profiling Assay to Predict Risk of Early Events in Follicular LymphomaUniversity of Arizona Session Fri, Nov 13 3:45pm–4:45pm Technical Topics Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Technical Topics 3:45pm–4:45pmStepping Towards Single-Molecule Protein Sequencing Using NanoporesUniversity of Washington Session Sat, Nov 14 2:30pm–4:00pm Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms 611-614, Level 6, Arch at 705 Pike Hematopathology · Technical Topics 2:30pm–2:45pmMeasurable Residual Disease Testing in Acute Myeloid Leukemia: Moving From Theory to PracticeVirginia Tech 2:45pm–4:00pmToward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid BiopsiesStanford University
University of Michigan Ann Arbor, MI
umich.edu Med centres Public research university and academic medical centre in Ann Arbor with clinical cancer genomics and molecular diagnostics programmes.	Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias 608-609, Level 6, Arch at 705 Pike Hematopathology 10:15am–10:45amLong-Read Transcriptome Sequencing Enables Accessible Molecular Diagnostics for Pediatric LeukemiaUniversity of North Carolina at Chapel Hill 10:45am–11:15amNew Insights from Gene Expression Profiling of Anaplastic Large Cell LymphomaMayo Clinic Session Thu, Nov 12 10:15am–11:45am Technical Advancement in Spatial Genomics and Multi-omics 602-604, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amSpatial Multi-Omics Profiling in TissuesUniversity of Pennsylvania 11:00am–11:45amMolecular-Resolution Spatial Inference of Subcellular Transcriptional ProgramsUniversity of Michigan Talk Thu, Nov 12 11:00am–11:45am Part of Technical Advancement in Spatial Genomics and Multi-omics Molecular-Resolution Spatial Inference of Subcellular Transcriptional Programs Submicron spatial transcriptomics plus segmentation-free analysis that assigns cell type and transcriptional programs from individual transcripts. 602-604, Level 6, Arch at 705 Pike Technical Topics Workshop Thu, Nov 12 12:40pm–1:10pm AI in Trainee Education: A Demonstration and Discussion Building a large language model study aid for pathology trainees, alongside survey findings on how trainees and educators use AI. Innovation Spotlight Stage #3 Talk Thu, Nov 12 8:30am–8:45am Opening Remarks Ballroom ABC, Level 6, Arch at 705 Pike 8:30am–8:45amOpening Remarks Talk Fri, Nov 13 2:00pm–2:45pm Part of Menin Inhibitors and Targeted Therapy Resistance in AML Development and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid Leukemia Development of menin inhibitors for KMT2A-rearranged and NPM1-mutant acute myeloid leukemia, plus response biomarkers and resistance. 608-609, Level 6, Arch at 705 Pike Hematopathology Poster Fri, Nov 13 7:15am–7:30am Part of Platform Presentations of Selected HemePath Abstracts I H069 Using Optical Genome Mapping in Standard-of-care of Acute Leukemias: 7 Months’ Clinical Experience
Memorial Sloan Kettering Cancer Center New York, NY
mskcc.org Med centres Cancer hospital and research institute in New York with a large clinical tumour sequencing and molecular diagnostics programme.	Session Thu, Nov 12 1:15pm–2:15pm Solid Tumors Plenary Session Ballroom ABC, Level 6, Arch at 705 Pike Solid Tumors 1:15pm–2:15pmDNA Methylation and Artificial Intelligence for the Diagnosis and Classification of CNS TumorsMayo Clinic Talk Thu, Nov 12 2:30pm–3:00pm Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting AMP Clinical Validation of cfDNA and ctDNA Assays Working Group Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development. Ballroom E, Level 6, Arch at 705 Pike Talk Thu, Nov 12 3:00pm–3:30pm Part of AMP Clinical Practice Committee Work in Progress Updates - NGS Validation and Reporting AMP Copy Number Alterations Working Group Copy number alterations called from sequencing: how those assays are validated, reported and read next to FISH, cytogenetics and microarray. Ballroom E, Level 6, Arch at 705 Pike Workshop Thu, Nov 12 4:25pm–4:55pm Want to get involved with AMP? Volunteering pathways in the professional society, from short time-limited tasks through committee membership and leadership roles. Innovation Spotlight Stage #3 Session Fri, Nov 13 10:15am–11:45am Accelerating the Impact of Molecular Profiling in Pediatric and Adolescent Young Adult (AYA) Tumors Ballroom E, Level 6, Arch at 705 Pike Hematopathology · Solid Tumors 10:15am–11:00amFrom Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA CancersBoston Children's Hospital/ Dana Farber Cancer Institute 11:00am–11:45amPresentation Title TBD Talk Fri, Nov 13 11:15am–11:45am Part of Resolving the Unknown: Functional and Computational Approaches to Determine Pathogenicity of Genetic Variants AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in Cancer Using AlphaMissense and related AI tools to flag pathogenic missense variants in DNA damage repair genes in cancer. 611-614, Level 6, Arch at 705 Pike Genetics Talk Fri, Nov 13 1:15pm–2:45pm Part of Optimizing Computational Infrastructure for High-throughput Clinical Data Data Analysis, Interpretation, and Discovery in 100,000 Patients With Cancer Combining somatic, germline and clinical data from over 100,000 cancer patients to support variant interpretation, trials and discovery. 611-614, Level 6, Arch at 705 Pike Informatics Session Sat, Nov 14 10:15am–11:45am Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors Ballroom E, Level 6, Arch at 705 Pike Solid Tumors 10:15am–11:00amMinimal Residual Disease in Colorectal Cancer: Opportunities for therapeutic developmentThe University of Texas MD Anderson Cancer Center, Houston, TX 11:00am–11:45amLiquid Biopsy Biomarkers for Early Detection of Treatment Response and Disease MonitoringMCGill University, Research Institute of the McGill University Health Centre Session Sat, Nov 14 1:15pm–2:15pm Platform Presentations of Selected Solid Tumor Abstracts II 611-614, Level 6, Arch at 705 Pike 1:15pm–1:30pmST026 Comparative Analysis of Copy Number Variant Detection from DNA Methylation Arrays Against Targeted Next-Generation Sequencing in a Pan-Cancer CohortNYU Langone Health 1:30pm–1:45pmST074 Integration of Longitudinal ctDNA Sequencing and Quantitative ESR1 Mutation Analysis to Inform Molecular Monitoring Strategies in Metastatic Breast CancerEarle A Chiles Research Institute, Providence Health 1:45pm–2:00pmST015 Clinical Evaluation of Whole Genome Enzymatic Methylation Sequencing for Integrated Classification and Copy Number Profiling of Pediatric Central Nervous System TumorsChildren's Hospital Los Angeles, University of Southern California 2:00pm–2:15pmST093 Tumor Cellularity Limits Next-Generation Sequencing Sensitivity for MTAP Loss: Post-Validation Next-Generation Sequencing-Immunohistochemistry Concordance in a Large Single-Institution CohortM.D. Anderson Cancer Center